Identification of heregulin, a specific activator of p185erbB2
- PMID: 1350381
- DOI: 10.1126/science.256.5060.1205
Identification of heregulin, a specific activator of p185erbB2
Abstract
The proto-oncogene designated erbB2 or HER2 encodes a 185-kilodalton transmembrane tyrosine kinase (p185erbB2), whose overexpression has been correlated with a poor prognosis in several human malignancies. A 45-kilodalton protein heregulin-alpha (HRG-alpha) that specifically induced phosphorylation of p185erbB2 was purified from the conditioned medium of a human breast tumor cell line. Several complementary DNA clones encoding related HRGs were identified, all of which are similar to proteins in the epidermal growth factor family. Scatchard analysis of the binding of recombinant HRG to a breast tumor cell line expressing p185erbB2 showed a single high affinity binding site [dissociation constant (Kd) = 105 +/- 15 picomolar]. Heregulin transcripts were identified in several normal tissues and cancer cell lines. The HRGs may represent the natural ligands for p185erbB2.
Similar articles
-
Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2.Science. 1990 Sep 28;249(4976):1552-5. doi: 10.1126/science.2218496. Science. 1990. PMID: 2218496
-
Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.Nature. 1993 Dec 2;366(6454):473-5. doi: 10.1038/366473a0. Nature. 1993. PMID: 7902537
-
Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.J Biol Chem. 1994 May 20;269(20):14661-5. J Biol Chem. 1994. PMID: 7514177
-
Neu and its ligands: from an oncogene to neural factors.Bioessays. 1993 Dec;15(12):815-24. doi: 10.1002/bies.950151207. Bioessays. 1993. PMID: 7908191 Review.
-
The epidermal growth factor receptor and its ligands.Cancer Treat Res. 1989;47:143-68. doi: 10.1007/978-1-4613-1599-5_6. Cancer Treat Res. 1989. PMID: 2576995 Review. No abstract available.
Cited by
-
The case for neuregulin-1 as a clinical treatment for stroke.Front Cell Neurosci. 2024 Apr 4;18:1325630. doi: 10.3389/fncel.2024.1325630. eCollection 2024. Front Cell Neurosci. 2024. PMID: 38638304 Free PMC article. Review.
-
Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors.Glob Med Genet. 2024 Feb 27;11(1):86-99. doi: 10.1055/s-0044-1781457. eCollection 2024 Jan. Glob Med Genet. 2024. PMID: 38414979 Free PMC article. Review.
-
Neuregulin 1 (NRG1) and its receptors in the enteric nervous system and other parts of the gastrointestinal wall.Histol Histopathol. 2024 Sep;39(9):1089-1099. doi: 10.14670/HH-18-721. Epub 2024 Feb 14. Histol Histopathol. 2024. PMID: 38407437 Review.
-
Fluorescent in situ hybridization has limitations in screening NRG1 gene rearrangements.Diagn Pathol. 2024 Jan 3;19(1):1. doi: 10.1186/s13000-023-01424-7. Diagn Pathol. 2024. PMID: 38173003 Free PMC article.
-
Reduction of experimental ocular axial elongation by neuregulin-1 antibody.Front Med (Lausanne). 2023 Oct 26;10:1277180. doi: 10.3389/fmed.2023.1277180. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37964886 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
